Equilibrio ácido-base y COVID largo::  comentarios sobre las alteraciones metabólico-respiratorias

Brian Johan Bustos-Viviescas; Rafael Enrique Lozano Zapata; Carlos Enrique García Yerena

doi:10.31053/1853.0605.v80.n4.42580

Autores

Brian Johan Bustos-Viviescas Servicio Nacional de Aprendizaje
Rafael Enrique Lozano Zapata Universidad de Pamplona
Carlos Enrique García Yerena Universidad del Magdalena

DOI:

https://doi.org/10.31053/1853.0605.v80.n4.42580

Palavras-chave:

Alcalose, Acidose, Ventilação, COVID-19

Resumo

A COVID longa é uma patologia multiorgânica com sequelas importantes que afectam a saúde e o bem-estar dos sobreviventes a partir da bioenergética celular, neste caso, foi abordada a importância de considerar o equilíbrio ácido-base dentro dos processos de avaliação e tratamento da COVID longa por profissionais de saúde e desporto, dado que diferentes investigações encontraram modificações importantes na função mitocondrial que resultam em falhas de ventilação, provocando alterações na compensação-descompensação do controlo do pH respiratório e renal (acidose e alcalose metabólico-respiratória).

Biografia do Autor

Brian Johan Bustos-Viviescas, Servicio Nacional de Aprendizaje

Instructor del Centro de Comercio y Servicios, SENA Regional Risaralda. Pereira, Colombia.
Rafael Enrique Lozano Zapata, Universidad de Pamplona

Docente de la Universidad de Pamplona. Villa del Rosario, Colombia.
Carlos Enrique García Yerena, Universidad del Magdalena

Docente de la Universidad del Magdalena. Santa Marta, Colombia.

Referências

1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations [published correction appears in Nat Rev Microbiol. 2023;21(6):408]. Nat Rev Microbiol. 2023;21(3):133-146. DOI: 10.1038/s41579-022-00846-2

2. Rivas-Vazquez RA, Rey G, Quintana A, Rivas-Vazquez AA. Assessment and Management of Long COVID [published correction appears in J Health Serv Psychol. 2022;48(3):141]. J Health Serv Psychol. 2022;48(1):21-30. doi: 10.1007/s42843-022-00055-8

3. Chen TH, Chang CJ, Hung PH. Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder. Int J Mol Sci. 2023;24(9):8034. 2023. doi: 10.3390/ijms24098034

4. McKenna HT, O'Brien KA, Fernandez BO, Minnion M, Tod A, McNally BD, West JA, Griffin JL, Grocott MP, Mythen MG, Feelisch M, Murray AJ, Martin DS. Divergent trajectories of cellular bioenergetics, intermediary metabolism and systemic redox status in survivors and non-survivors of critical illness. Redox Biol. 2021 May;41:101907. doi: 10.1016/j.redox.2021.101907.

5. Alfano G, Fontana F, Mori G, Giaroni F, Ferrari A, Giovanella S, Ligabue G, Ascione E, Cazzato S, Ballestri M, Di Gaetano M, Meschiari M, Menozzi M, Milic J, Andrea B, Franceschini E, Cuomo G, Magistroni R, Mussini C, Cappelli G, Guaraldi G; Modena Covid-19 Working Group (MoCo19). Acid base disorders in patients with COVID-19. Int Urol Nephrol. 2022 Feb;54(2):405-410. doi: 10.1007/s11255-021-02855-1.

6. Zemlin AE, Sigwadhi LN, Wiese OJ, Jalavu TP, Chapanduka ZC, Allwood BW, Tamuzi JL, Koegelenberg CF, Irusen EM, Lalla U, Ngah VD, Yalew A, Erasmus RT, Matsha TE, Zumla A, Nyasulu PS; COVID-19 Research Response Collaboration. The association between acid-base status and clinical outcome in critically ill COVID-19 patients admitted to intensive care unit with an emphasis on high anion gap metabolic acidosis. Ann Clin Biochem. 2023 Mar;60(2):86-91. doi: 10.1177/00045632221134687

7. Al-Azzam N, Khassawneh B, Al-Azzam S, Karasneh RA, Aldeyab MA. Acid-base imbalance as a risk factor for mortality among COVID-19 hospitalized patients. Biosci Rep. 2023;43(3):BSR20222362. doi: 10.1042/BSR20222362

8. Zhang Y, Wang S, Xia H, Guo J, He K, Huang C, Luo R, Chen Y, Xu K, Gao H, Sheng J, Li L. Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected Patients Through Single-Cell Transcriptome Sequencing. Engineering (Beijing). 2022 Oct;17:161-169. doi: 10.1016/j.eng.2021.05.009.

9. Jia H, Liu C, Li D, Huang Q, Liu D, Zhang Y, Ye C, Zhou D, Wang Y, Tan Y, Li K, Lin F, Zhang H, Lin J, Xu Y, Liu J, Zeng Q, Hong J, Chen G, Zhang H, Zheng L, Deng X, Ke C, Gao Y, Fan J, Di B, Liang H. Metabolomic analyses reveal new stage-specific features of COVID-19. Eur Respir J. 2022 Feb 24;59(2):2100284. doi: 10.1183/13993003.00284-2021.

10. Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, Agarwal K. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol. 2021 Jan 1;320(1):C57-C65. doi: 10.1152/ajpcell.00426.2020.

11. Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, Jimenez Restrepo JL, Vendramini PH, Reis-de-Oliveira G, Bispo Dos Santos K, Toledo-Teixeira DA, Parise PL, Martini MC, Marques RE, Carmo HR, Borin A, Coimbra LD, Boldrini VO, Brunetti NS, Vieira AS, Mansour E, Ulaf RG, Bernardes AF, Nunes TA, Ribeiro LC, Palma AC, Agrela MV, Moretti ML, Sposito AC, Pereira FB, Velloso LA, Vinolo MAR, Damasio A, Proença-Módena JL, Carvalho RF, Mori MA, Martins-de-Souza D, Nakaya HI, Farias AS, Moraes-Vieira PM. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis. Cell Metab. 2020 Sep 1;32(3):437-446.e5. doi: 10.1016/j.cmet.2020.07.007. Epub 2020 Jul 17. Erratum in: Cell Metab. 2020 Sep 1;32(3):498-499.

12. Izadpanah A, Mudd JC, Garcia JGN, Srivastav S, Abdel-Mohsen M, Palmer C, Goldman AR, Kolls JK, Qin X, Rappaport J. SARS-CoV-2 infection dysregulates NAD metabolism. Front Immunol. 2023 Jun 29;14:1158455. doi: 10.3389/fimmu.2023.1158455.

13. Nunn AVW, Guy GW, Brysch W, Bell JD. Understanding Long COVID; Mitochondrial Health and Adaptation-Old Pathways, New Problems. Biomedicines. 2022;10(12):3113. 2022. doi: 10.3390/biomedicines10123113

14. Kitala D, Łabuś W, Kozielski J, Strzelec P, Nowak M, Knefel G, Dyjas P, Materniak K, Kosmala J, Pająk J, Czop J, Janda-Kalus B, Marona B, Nowak-Wróżyna A, Gierek M, Szczegielniak J, Kucharzewski M. Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome. J Clin Med. 2022 Dec 30;12(1):308. doi: 10.3390/jcm12010308.

15. Block T, Kuo J. Rationale for Nicotinamide Adenine Dinucleotide (NAD+) Metabolome Disruption as a Pathogenic Mechanism of Post-Acute COVID-19 Syndrome. Clin Pathol. 2022;15:2632010X221106986. 2022. doi: 10.1177/2632010X221106986

16. Cristea AM, Zaharia DC, Leu S, Bogdan MA. Complications During Hospitalization in Patients With SARS-CoV-2 Pneumonia in a Romanian Pulmonary Center. Cureus. 2023;15(1):e33882. 2023. doi: 10.7759/cureus.33882